Academic Journals Database
Disseminating quality controlled scientific knowledge

SCCA VERSUS THE AFP ASSESSMENT IN EARLY DIAGNOSIS OF HEPATOCARCINOMA

ADD TO MY LIST
 
Author(s): Irina Teofănescu | Elena Gologan | Gabriela Ştefănescu | Gh. Bălan

Journal: Jurnalul de Chirurgie
ISSN 1584-9341

Volume: 6;
Issue: 3;
Start page: 237;
Date: 2010;
VIEW PDF   PDF DOWNLOAD PDF   Download PDF Original page

Keywords: HEPATOCELLULAR CARCINOMA | ALPHA-FETOPROTEIN | SQUAMOUS CELL CARCINOMA ANTIGEN | IMMUNE COMPLEXES WITH SCCA | AND IMMUNE COMPLEXES WITH AFP

ABSTRACT
Hepatocellular carcinoma is on the fifth place among malign tumours, with almost one million new cases yearly. Its incidence is raising as well its mortality. Because the only thing corelated with long term survival is its early detection all the efforts targeted the finding of the best screening and surveillance method in order to provide an early diagnosis. Hepatocellular carcinoma, having a wellknown premalign condition [liver cyrrhosis], can be early diagnosed by using biomarkers. Until now AFP, the only marker used for diagnosis, has failed mainly because its poor sensitivity. Ultrasonography is a very important tehnique for detecting early hepatocellular carcinoma but because it is operator dependent and machine dependent can give false positive results. It has been chosen to combine this method with AFP level detecting in order to early diagnose hepatocellular carcinoma. The biologic properties of new markers [SCCA, immune complexes with SCCA, AFP and immune complexes with AFP] as well as their combined use with ultrasonography bring new hope for the early diagnosis of hepatocellular carcinoma.

Tango Rapperswil
Tango Rapperswil

     Save time & money - Smart Internet Solutions